ONMETIO Trademark

Trademark Overview

On Friday, April 24, 2015, a trademark application was filed for ONMETIO with the United States Patent and Trademark Office. The USPTO has given the ONMETIO trademark a serial number of 79167522. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, April 24, 2025. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The ONMETIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for treating cancer and immune disorders; pharmaceutical preparations for treating cancer and immune disorders
onmetio

General Information

Serial Number79167522
Word MarkONMETIO
Filing DateFriday, April 24, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, April 24, 2025
Registration Number4911463
Registration DateTuesday, March 8, 2016
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 22, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "ONMETIO".
Goods and ServicesPharmaceutical compositions for treating cancer and immune disorders; pharmaceutical preparations for treating cancer and immune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, June 25, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Monday, July 20, 2015NON-FINAL ACTION WRITTEN
Tuesday, July 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 22, 2015NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, August 20, 2015NON-FINAL ACTION WRITTEN
Thursday, August 20, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 21, 2015REFUSAL PROCESSED BY MPU
Friday, August 21, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 12, 2015REFUSAL PROCESSED BY IB
Tuesday, October 13, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 13, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2015NOTICE OF PUBLICATION
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 22, 2015PUBLISHED FOR OPPOSITION
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, June 8, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 20, 2016FINAL DISPOSITION PROCESSED
Monday, June 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 23, 2022CANCELLED SECTION 71
Tuesday, May 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, June 26, 2023INVALIDATION PROCESSED
Monday, June 26, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, July 21, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, November 15, 2025DEATH OF INTERNATIONAL REGISTRATION

Related Keywords

onmetio immune disorders pharmaceutical cancer treating preparations compositions